161.50
price up icon15.66%   21.87
after-market Handel nachbörslich: 161.41 -0.09 -0.06%
loading
Schlusskurs vom Vortag:
$139.63
Offen:
$150
24-Stunden-Volumen:
4.13M
Relative Volume:
2.64
Marktkapitalisierung:
$13.04B
Einnahmen:
$8.19B
Nettoeinkommen (Verlust:
$758.19M
KGV:
17.59
EPS:
9.18
Netto-Cashflow:
$1.06B
1W Leistung:
+10.94%
1M Leistung:
+10.25%
6M Leistung:
-20.47%
1J Leistung:
-52.49%
1-Tages-Spanne:
Value
$150.00
$161.72
1-Wochen-Bereich:
Value
$139.15
$161.72
52-Wochen-Spanne:
Value
$125.10
$339.88

Icon Plc Stock (ICLR) Company Profile

Name
Firmenname
Icon Plc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
41,250
Name
Twitter
@ICONplc
Name
Nächster Verdiensttermin
2025-07-23
Name
Neueste SEC-Einreichungen
Name
ICLR's Discussions on Twitter

Vergleichen Sie ICLR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
ICLR
Icon Plc
161.50 11.57B 8.19B 758.19M 1.06B 9.18
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
427.62 157.79B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
189.91 138.02B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
532.00 42.36B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
116.19 32.08B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
187.38 27.28B 15.50B 1.33B 2.16B 7.34

Icon Plc Stock (ICLR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-29 Herabstufung JP Morgan Overweight → Neutral
2025-04-14 Herabstufung TD Cowen Buy → Hold
2025-04-10 Herabstufung Barclays Overweight → Equal Weight
2025-03-21 Herabstufung Goldman Buy → Neutral
2025-01-07 Eingeleitet RBC Capital Mkts Outperform
2024-10-24 Herabstufung Robert W. Baird Outperform → Neutral
2024-10-14 Eingeleitet Redburn Atlantic Neutral
2024-09-18 Eingeleitet Leerink Partners Outperform
2024-06-06 Eingeleitet Goldman Buy
2023-12-15 Eingeleitet Truist Buy
2023-09-13 Eingeleitet TD Cowen Outperform
2023-01-17 Hochstufung Barclays Equal Weight → Overweight
2023-01-13 Hochstufung Barclays Equal Weight → Overweight
2022-11-09 Hochstufung BofA Securities Neutral → Buy
2022-09-07 Eingeleitet UBS Buy
2022-08-25 Eingeleitet Credit Suisse Neutral
2022-05-24 Eingeleitet Guggenheim Buy
2022-04-25 Herabstufung Wells Fargo Overweight → Equal Weight
2022-04-12 Hochstufung Deutsche Bank Hold → Buy
2021-09-27 Hochstufung JP Morgan Neutral → Overweight
2021-08-05 Fortgesetzt Credit Suisse Outperform
2021-07-23 Hochstufung Citigroup Neutral → Buy
2021-07-14 Eingeleitet Citigroup Neutral
2021-04-13 Fortgesetzt BofA Securities Neutral
2021-04-01 Hochstufung Wells Fargo Equal Weight → Overweight
2021-03-08 Hochstufung Robert W. Baird Neutral → Outperform
2021-03-03 Eingeleitet Barclays Equal Weight
2021-03-01 Hochstufung UBS Neutral → Buy
2021-02-26 Hochstufung Truist Hold → Buy
2020-07-24 Herabstufung BofA Securities Buy → Neutral
2020-04-20 Herabstufung Robert W. Baird Outperform → Neutral
2020-03-26 Hochstufung Barclays Equal Weight → Overweight
2020-03-02 Eingeleitet Deutsche Bank Hold
2020-01-27 Herabstufung SunTrust Buy → Hold
2020-01-08 Eingeleitet Wells Fargo Equal Weight
2020-01-07 Eingeleitet Citigroup Neutral
2019-09-23 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2019-07-26 Hochstufung UBS Sell → Neutral
2019-01-25 Hochstufung Mizuho Neutral → Buy
2018-10-26 Hochstufung Evercore ISI In-line → Outperform
2018-10-09 Eingeleitet UBS Sell
2018-04-03 Herabstufung Evercore ISI Outperform → In-line
2018-02-15 Bestätigt Mizuho Neutral
2018-01-19 Eingeleitet Evercore ISI Outperform
2017-10-27 Bestätigt Barclays Equal Weight
2017-09-11 Eingeleitet BofA/Merrill Buy
2017-07-31 Hochstufung SunTrust Hold → Buy
2017-07-27 Bestätigt Mizuho Neutral
2017-06-29 Hochstufung Jefferies Hold → Buy
Alle ansehen

Icon Plc Aktie (ICLR) Neueste Nachrichten

pulisher
Jul 22, 2025

ICON plc’s Market Surge: Examining Strong Moves - timothysykes.com

Jul 22, 2025
pulisher
Jul 22, 2025

ICON plc Emerges as Top Contender in Clinical Research Arena - timothysykes.com

Jul 22, 2025
pulisher
Jul 22, 2025

Icon (ICLR) Shares Surge Over 14% to Reach $160 | ICLR Stock New - GuruFocus

Jul 22, 2025
pulisher
Jul 21, 2025

ICON PLC expected to post earnings of $3.21 a shareEarnings Preview - TradingView

Jul 21, 2025
pulisher
Jul 20, 2025

Icon ICLR 2025Q2 Earnings Preview Downside Risk Amid Macroeconomic Issues and Trial Delays - AInvest

Jul 20, 2025
pulisher
Jul 19, 2025

Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

ICON (NASDAQ:ICLR) Seems To Use Debt Quite Sensibly - 富途牛牛

Jul 18, 2025
pulisher
Jul 18, 2025

Medical Device Regulatory Affairs Market Key Players Analysis - openPR.com

Jul 18, 2025
pulisher
Jul 16, 2025

Launch Your Career as a Life Science Intern at ICON, Apply Now! - BioTecNika

Jul 16, 2025
pulisher
Jul 16, 2025

ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report - Business Wire

Jul 16, 2025
pulisher
Jul 15, 2025

Do You Believe in the Upside Potential of ICON PLC (ICLR)? - Insider Monkey

Jul 15, 2025
pulisher
Jul 14, 2025

Clinical Trial Investigative Site Network Market Top Players - openPR.com

Jul 14, 2025
pulisher
Jul 13, 2025

Icon (ICLR) Gets a Buy from Leerink Partners - The Globe and Mail

Jul 13, 2025
pulisher
Jul 10, 2025

Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating, Announces Target Price $187 - 富途牛牛

Jul 10, 2025
pulisher
Jul 09, 2025

ICON plc stock price target lowered to $187 at Truist Securities - Investing.com Nigeria

Jul 09, 2025
pulisher
Jul 09, 2025

ICON plc stock price target lowered to $187 at Truist Securities By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 09, 2025

WCM Investment Management Reduces Stake in Icon PLC, Focuses on Tech and Financial Sectors - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

WCM Investment Management, LLC Significantly Reduces Stake in Ic - GuruFocus

Jul 08, 2025
pulisher
Jul 08, 2025

WCM Investment Management, LLC Significantly Reduces Stake in Icon PLC - GuruFocus

Jul 08, 2025
pulisher
Jul 07, 2025

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability - 01net

Jul 07, 2025
pulisher
Jul 07, 2025

ICON and Its Employees Recognised as Clinical Research Industry - GuruFocus

Jul 07, 2025
pulisher
Jul 05, 2025

Should You Hold ICON PLC (ICLR)? - MSN

Jul 05, 2025
pulisher
Jul 03, 2025

Will ICON PLC (ICLR) Benefit from R&D Spending? - Insider Monkey

Jul 03, 2025
pulisher
Jun 25, 2025

BofA Securities Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $170 - 富途牛牛

Jun 25, 2025
pulisher
Jun 23, 2025

ICON plc Schedules Q2 2025 Earnings Call - TipRanks

Jun 23, 2025
pulisher
Jun 23, 2025

ICON Announces Q2 2025 Earnings Call - AInvest

Jun 23, 2025
pulisher
Jun 18, 2025

ICON plc Reports Strong Interim Financial Results for Early 2025 - TipRanks

Jun 18, 2025
pulisher
Jun 17, 2025

Icon (ICLR) Receives Positive Rating from Truist Financial Analyst - AInvest

Jun 17, 2025
pulisher
Jun 13, 2025

Medical Device Regulatory Affairs Market Top PlayersICON, - openPR.com

Jun 13, 2025
pulisher
Jun 11, 2025

ICON plc Announces 2025 AGM and Key Resolutions - TipRanks

Jun 11, 2025
pulisher
Jun 07, 2025

Icon PLC (ICLR) Shares Up 3.47% on Jun 6 - GuruFocus

Jun 07, 2025
pulisher
Jun 05, 2025

Regulatory Affairs Outsourcing Market Analysis Report 2025: Globalization of Biopharmaceutical and Medical Device Companies Bolster Growth - GlobeNewswire Inc.

Jun 05, 2025
pulisher
Jun 05, 2025

ICON Public Limited (NASDAQ:ICLR) Short Interest Up 25.4% in May - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Icon PLC (ICLR) Stock Price Up 4.49% on Jun 4 - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

ICON at William Blair Conference: Strategic Focus Amid Challenges - Investing.com

Jun 04, 2025
pulisher
Jun 03, 2025

ICON Becomes the First Large Clinical Research Organization to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management and Review - mx.advfn.com

Jun 03, 2025
pulisher
Jun 02, 2025

Here's Why You Should Retain ICLR Stock in Your Portfolio Now - TradingView

Jun 02, 2025
pulisher
May 30, 2025

Icon PLC (ICLR) Down 9.7% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

May 30, 2025
pulisher
May 27, 2025

ICON plc to Present at the William Blair 45th Annual Growth Stoc - GuruFocus

May 27, 2025
pulisher
May 27, 2025

ICON plc to Present at Annual Growth Stock Conference By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

ICLR December 2026 Options Begin Trading - Nasdaq

May 27, 2025
pulisher
May 27, 2025

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference - BioSpace

May 27, 2025
pulisher
May 27, 2025

ICON plc to Present at Annual Growth Stock Conference - Investing.com

May 27, 2025
pulisher
May 27, 2025

ICON plc to Present at William Blair Growth Stock Conference - TipRanks

May 27, 2025
pulisher
May 25, 2025

ICON’s SWOT analysis: cro stock faces headwinds amid potential rebound - Investing.com

May 25, 2025
pulisher
May 23, 2025

ICON Life Science Internship For BSc & MSc – Applications Closing Soon! Hurry! - BioTecNika

May 23, 2025
pulisher
May 23, 2025

Redburn Atlantic Adjusts Icon (ICLR) Price Target Amid Market Uncertainty | ICLR Stock News - GuruFocus

May 23, 2025
pulisher
May 21, 2025

ICON Plc stock hits 52-week low at $127.51 amid market challenges By Investing.com - Investing.com South Africa

May 21, 2025
pulisher
May 21, 2025

ICON Plc stock hits 52-week low at $127.51 amid market challenges - Investing.com Nigeria

May 21, 2025

Finanzdaten der Icon Plc-Aktie (ICLR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research WAT
$287.46
price up icon 2.06%
$139.92
price down icon 0.50%
diagnostics_research DGX
$178.24
price up icon 7.08%
diagnostics_research LH
$252.07
price up icon 3.72%
diagnostics_research MTD
$1,218.96
price up icon 4.50%
diagnostics_research IQV
$187.38
price up icon 17.88%
Kapitalisierung:     |  Volumen (24h):